Cite
HARVARD Citation
Valle, J. et al. (2021). Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study. Lancet oncology. 22 (10), pp. 1468-1482. [Online].